Compare ASMB & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASMB | GCO |
|---|---|---|
| Founded | 2005 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 512.1M | 432.0M |
| IPO Year | 2010 | 1994 |
| Metric | ASMB | GCO |
|---|---|---|
| Price | $26.49 | $39.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $44.20 | $33.00 |
| AVG Volume (30 Days) | 140.4K | ★ 144.4K |
| Earning Date | 05-06-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 91.78 | ★ 171.84 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,606,898,000.00 |
| Revenue This Year | N/A | $0.78 |
| Revenue Next Year | $638.39 | $2.12 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 13.71 |
| 52 Week Low | $18.50 | $21.93 |
| 52 Week High | $39.71 | $43.60 |
| Indicator | ASMB | GCO |
|---|---|---|
| Relative Strength Index (RSI) | 45.20 | 60.49 |
| Support Level | $21.80 | $31.11 |
| Resistance Level | $30.36 | $43.60 |
| Average True Range (ATR) | 1.30 | 1.53 |
| MACD | -0.12 | 0.35 |
| Stochastic Oscillator | 18.77 | 74.31 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Genesco Inc sells footwear, headwear, sports apparel, and accessories. It has four reportable business segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass. The brands of the company are: Journeys; Journeys Kidz; Little Burgundy; Schuh; Johnston & Murphy; and Genesco Brands Group.